Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain
  2. Kim, Taejin; Viard,Mathias; Afonin, Kirill A; Gupta, Kshitij; Popov, Mary; Salotti,Jacqueline; Johnson,Peter; Linder, Charles; Heldman, Eliahu; Shapiro,Bruce
  3. Molecular therapy. Nucleic acids. 2020, JUN 5; 20: 359-372.
  1. 2.   siRNA containing a unique 5-nucleotide motif acts as a quencher of IFI16-mediated innate immune response
  2. Sui,Hongyan; Yang,Jun; Hu,Xiaojun; Chen,Qian; Imamichi,Tomozumi
  3. MOLECULAR IMMUNOLOGY. 2019, OCT; 114: 330-340.
  1. 3.   MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival
  2. Lee, Chih-Shia; Lee, Liam C.; Yuan, Tina L.; Chakka, Sirisha; Fellmann, Christof; Lowe, Scott W.; Caplen, Natasha J.; McCormick, Frank; Luo, Ji
  3. Proceedings of the National Academy of Sciences of the United States of America. 2019, Mar 5; 116(10): 4508-4517.
  1. 4.   Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
  2. Burks, Julian; Nadella, Sandeep; Mahmud, Abdullah; Mankongpaisarnrung, Charoen; Wang, Juan; Hahm, Jong-In; Tucker, Robin D; Shivapurkar, Narayan; Stern, Steve; Smith, Jill P
  3. Cellular and Molecular Gastroenterology and Hepatology. 2018, Mar 07; 6(1): 17-32.
  1. 5.   Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J. R.; Morris, N. L.; Anderson, L. M.
  3. International Journal of Cancer. 2012, Jan; 130(2): 251-258.
  1. 6.   Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
  2. Farrell, D.; Ptak, K.; Panaro, N. J.; Grodzinski, P.
  3. Pharmaceutical Research. 2011, Feb; 28(2): 273-278.
  1. 7.   Self-Assembling RNA Nanorings Based on RNAI/II Inverse Kissing Complexes
  2. Grabow, W. W.; Zakrevsky, P.; Afonin, K. A.; Chworos, A.; Shapiro, B. A.; Jaeger, L.
  3. Nano Letters. 2011, Feb; 11(2): 878-887.
  1. 8.   Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation
  2. Lee, S. L.; Huang, P. Y.; Roller, P.; Cho, E. G.; Park, D.; Dickson, R. B.
  3. Mechanisms of Development. 2010, Jan-Feb; 127(1-2): 82-95.
  1. 9.   Energy profile and secondary structure impact shRNA efficacy
  2. Zhou, H.; Zeng, X.
  3. Bmc Genomics. 2009 10
  1. 10.   Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3 ' untranslated region
  2. Vondruskova, E.; Malik, R.; Sevcik, J.; Kleiblova, P.; Kleibl, Z.
  3. Neoplasma. 2008 55(2): 130-137.
  1. 11.   RNA interference as a novel and powerful tool in immunopharmacological research
  2. Kong, Y.; Ruan, L. F.; Ma, L. L.; Cui, Y. H.; Wang, J. M.; Le, Y. Y.
  3. International Immunopharmacology. 2007, Apr; 7(4): 417-426.
  1. 12.   Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J.; Anderson, L. M.
  3. Oncogene. 2005, MAR 10; 24(11): 1847-1859.
  1. 13.   siRNA, miRNA and HIV: promises and challenges
  2. Yeung, M. L.; Bennasser, Y.; Le, S. Y.; Jeang, K. T.
  3. Cell Research. 2005, NOV-DEC; 15(11-12): 935-946.
  1. 14.   Cellular Delivery of siRNAs Using Bolaamphiphiles.
  2. Gupta, Kshitij
  3. Methods in molecular biology (Clifton, N.J.). 2017 1632: 187-205.
  1. 15.   RNA and DNA nanoparticles for triggering RNA interference
  2. El Tannir, Ziad; Afonin, Kirill A; Shapiro,Bruce
  3. RNA & disease (Houston, Tex.). 2015 2(Suppl 1):
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel